Appetite LossNCT05608707
APPETITE: Plant Protein and Exercise Solutions for the Prevention of Undernutrition in Older Adults.
A study testing Physical activity intervention and Personalised nutrition intervention in people with Appetite Loss and Physical Inactivity, run by University College Dublin at 3 sites in 3 countries.
Trial summary
The APPETITE Trial aims to investigate the efficacy of innovative plant protein fibre (PPF) products (developed in a previous workpackage) as part of a personalised diet with/out physical activity on appetite and incidence of undernutrition in older persons from three European countries at high risk of undernutrition. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Appetite Loss, Physical Inactivity, Undernutrition
- What is being tested?
- Physical activity intervention and Personalised nutrition intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 180 participants
- Where
- 3 sitesin 3 countries
- Study dates
- 22 Sep 2022to Sep 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- Community-dwelling,
- Age 65+ years,
- BMI 19.5-30.4kg/m2,
- Inactive (<150 minutes of moderate to vigorous physical activity per week and no regular resistance training),
- Have proof of Covid-19 vaccination
Who cannot join
- Major cognitive impairment (MMSE ≤24),
- Uncontrolled Clinical depression (CES-D >16),
- Medical condition or current medication known to impact appetite or energy intake,
- Other medical condition that may impact ability to participate in study or study outcomes,
- Heavy smoker (>10/day),
- Plans to relocate out of the study area within the next 6 months,
Show all 13Show fewer
- Inability to come to study centre/PA program location,
- Currently participating in another intervention study,
- Inability to participate in physical activity,
- Unable to walk across a room,
- Allergic to or unwilling to consume any of the study test foods,
- Loss of taste or smell associated with COVID-19,
- Unwilling to be randomised to any intervention group.
Trial locations and contacts
3 sites in 3 countries.
3 sites in 3 countries
Ireland1 site
School of Public Health, Physiotherapy and Sports Science
Dublin, Leinster
About this study
Official title: Innovative PlAnt Protein Fibre and Physical Activity Solutions to Address Poor AppEtite and PrevenT UndernutrITion in OldEr Adults (APPETITE)
The APPETITE Trial aims to investigate the efficacy of innovative plant protein fibre (PPF) products (developed in a previous workpackage) as part of a personalised diet with/out physical activity on appetite and incidence of undernutrition in older persons from three European countries at high risk of undernutrition.
Read the detailed description
It is normal that dietary intake decreases as we age due to reduced activity and muscle mass. However, appetite is a key determinant of dietary intake, and poor appetite can result in undernutrition. In many instances, older adults do not recognise their appetite has decreased significantly as the decline is slow and progressive. Protein and fibre are often poorly consumed in the diets of older adults with decreased appetite, but essential for health and well-being. Interventions designed to increase appetite, or increase dietary intake despite a reduced appetite, should therefore be key to preventing undernutrition (i.e. protein-energy malnutrition as well as nutrient deficiencies). However, treatment strategies for poor appetite are not well-established.
In this multi-centre randomised controlled trial conducted in Ireland, Germany, and Italy, a two-by-two factorial design will define the individual and combined impact of two intervention conditions over 12 weeks: 1) personalised diet with focus on plant-based protein plus fibre; and 2) physical activity.
At each centre, 60 older adults (180 in total) will be randomly allocated to one of the following four groups over a 12 week period: 1) personalised diet plus physical activity program (PD + PA), 2) usual diet plus physical activity (PA), 3) personalised diet and no PA (PD), and 4) control (usual diet, no PA).
Using identical procedures, two testing visits will be completed before and after the 12 intervention or control period.
- Conditions
- Appetite Loss, Physical Inactivity, Undernutrition, Anorexia of Aging, Aging, Ageing Well
- Being tested
- Physical activity intervention, Personalised nutrition intervention
- Keywords
- appetite, energy intake, nutrition, older adults, Physical activty
- Medical subject headings
- Anorexia, Sedentary Behavior, Malnutrition
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Physical activity interventionBehavioural
Also called Structured exercise program
The 12 week intervention will involve 2 weekly group exercise sessions incorporating strength and balance exercises, along with home-based exercise focused on increasing time spent walking.
Personalised nutrition interventionDietary supplement
Also called Plant-based protein and fibre intervention
Two Plant-based Protein and Fibre (PPF) product products have been selected from six initially developed, with best amino acid blend, taste, and bioavailability. Participants will be provided with the PPFs to consume daily as part of a personalised diet over 12 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Personalised diet plus physical activity intervention | Experimental | A personalised diet intervention involving the incorporation of the developed plant-based protein and fibre product.
Participants will also undertake 2 weekly group exercise sessions incorporating strength and balance exercises, along with home-based exercise Receives: Behavioral: Physical activity intervention; Dietary Supplement: Personalised nutrition intervention |
| Usual diet plus physical activity | Experimental | Participants will consume their usual diet and undertake 2 weekly group exercise sessions incorporating strength and balance exercises, along with home-based exercise Receives: Behavioral: Physical activity intervention |
| Personalised diet plus usual physical activity | Experimental | A personalised diet intervention involving the incorporation of the developed plant-based protein and fibre product. Receives: Dietary Supplement: Personalised nutrition intervention |
| Control (usual diet and physical activity) | No intervention | This arm will not be given any nutritional or physical activity support. They will be instructed to carry on with their usual activities. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Ad libitum energy intake (kcal)
12-week change in energy intake assessed at an an ad libitum lunch test meal
Measured: To be assessed at baseline and following a 12-week intervention or control period
Changes in subjective appetite sensations
12-week change in appetite to be assessed by Visual Analogue Scale (VAS) during a test meal challenge. The VAS is a validated tool for assessing subjective sensations such as hunger, fullness and desire to eat. On each 100-mm line, an appetite (hunger, fullness, desire to eat) sensation was paired with the opposing sensation (for example, 'hungry' and 'not hungry').
Measured: To be assessed at baseline and following a 12-week intervention or control period
Secondary outcomes (25)
7-day physical activity score as assessed by ActivPAL v4.0
12-week change in physical activity score will be assessed using 7-day accelerometery data. This is a validated device that is installed onto an individuals thigh for continuous readings. The data generated describes the amount of time spent engaging in physical activities and sedentary activities, and gives an output score in MET.h (Metabolic EquivalenT hour). This is a measure of energy usage over and above what is required at rest, where 1MET is equivalent to oxygen uptake of 3.5ml/kg body weight/minute
Measured: To be assessed at baseline, prior to commencing the intervention, and during week 12 of the intervention or control period
Resting Energy Expenditure (REE) (sub-sample)
12-week change in resting energy expenditure will be assessed using indirect calorimetry
Measured: To be assessed at baseline and following a 12-week intervention or control period
Handgrip strength
12-week change in handgrip strength will be assessed using a Jamar hydraulic hand dynamometer
Measured: To be assessed at baseline and following a 12-week intervention or control period
Isometric knee extension strength
12-week changes in isometric leg strength will be assessed using a seated leg extension dynamometer
Measured: To be assessed at baseline and following a 12-week intervention or control period
Cardiorespiratory fitness
12-week change in cardiorespiratory fitness will be assessed using the 400-meter walk test
Measured: To be assessed at baseline and following a 12-week intervention or control period
Physical performance
12-week change in physical function will be assessed using the Short Physical Activity Battery (SPPB)
Measured: To be assessed at baseline and following a 12-week intervention or control period
Participants subjective rating of perceived Quality of Life as assessed by the EQ-5D-5L
12-week changes in perceived quality of life will be assessed using the EuroQol (European Quality Of Life) questionnaire (EQ-5D-5L). This consists of self-assessed rating of health under 5 dimensions (Mobility, Self-Care, Usual Activity, Pain/Discomfort, Anxiety/Depression), and perceived overall health on a magnitude scale (0-100) anchored with opposing statements (0= the worst health you can imagine; 100= the best health you can imagine).
Measured: To be assessed at baseline and following a 12-week intervention or control period
Body composition (fat mass, fat free mass) by air displacement phlethysmography (sub-sample)
12-week change in body composition will be assessed using air displacement plethysmography (Bodpod).
Measured: To be assessed at baseline and following a 12-week intervention or control period
Cognitive Dietary Restraint
12-week change in dietary restraint will be assessed using the Cognitive Dietary Restraint (CDR) subscale of the Three Factor Eating Questionnaire (TFEQ). The questionnaire consists of a subscale of 6 questions relating to cognitive dietary restraint from the orignal 50 item questionnaire. The questions are a mix of 'true/false', and likert scale type answers.
Measured: To be assessed at baseline and following a 12-week intervention or control period
Dietary Record (energy, protein and fibre intake)
12-week change in energy, protein and fibre intake assessed using a three-day non-weighed dietary record
Measured: To be assessed at baseline and following a 12-week intervention or control period
Appetite hormones (Ghrelin, GLP-1, & PYY) (sub-sample)
12-week change in appetite-related gut hormone response to a fixed meal. Assessed in circulating peripheral bloods at fasting, and at regular intervals postprandially (minute 30, 60, 90, 120, 150, \& 180).
Measured: To be assessed at baseline and following a 12-week intervention or control period
Gut metabolomic profiles and gut microbiome diversity
12-week change in gut microbiota quality and diversity assessed by faecal matter and faecal water.
Measured: To be assessed at baseline and following a 12-week intervention or control period
Blood hormone and metabolite profile
12-week change in fasting peripheral blood profile (insulin, leptin, glucose, amino acid, fatty acid)
Measured: To be assessed at baseline and following a 12-week intervention or control period
Body composition by Bioelectrical Impedance Analysis (BIA)
Body composition will be assessed by BIA across all sites at baseline and post intervention. BIA is a quick non-invasive method of measuring body composition. Bioelectrical impedance analysis (BIA) measures body composition based on the rate at which an electrical current travels through the body. Body fat (adipose tissue) causes greater resistance (impedance) than lean mass and slows the rate at which the current travels. The device provides an output of absolute (Kg) and percentage (% of total mass) of fat mass (FM) and fat-free mass (FFM).
Measured: To be assessed at baseline and following a 12-week intervention or control period
Appetite by Simplified Nutritional Appetite Questionnaire (SNAQ)
The SNAQ questionnaire is used to assess an older adults usual appetite. The SNAQ is a self-administered questionnaires adapted from the Appetite, Hunger and Sensory Perception questionnaire (AHSP), an appetite assessment tool validated among community-dwelling older adults. It consists of 4 multiple choice statements, where an individual reads the beginning of the statement and is presented with 5 options that best describe their situation. Each question derives a score between 1 - 5 with lower scores indicating poorer appetite. The questionnaire scores between 4 - 20 with scores </= 14 indicating poor appetite.
Measured: To be assessed at baseline and following a 12-week intervention or control period
Test meal palatability by Visual Analogue Scale (VAS)
Rating of the breakfast and lunch test meals by visual analogue scales (VAS). The VAS is a validated tool for assessing subjective sensory experience. On each 100-mm line, a question is asked relating to sensory aspects of the meal (E.g., How pleasant was the meal?). The subject will mark along the 100mm line where they feel their experience, in terms of the question, rests. On ether end of the 100mm line are opposing terms (E.g., "not at all", "extremely").
Measured: To be assessed at baseline and following a 12-week intervention or control period
Body weight (kg)
Body weight will be measure using a calibrated scales, shoes and heavy clothing removes, and recorded in kilograms.
Measured: To be assessed at baseline and following a 12-week intervention or control period
Standing height (cm)
Height will be measured in centimetres using a stadiometer. Participants will be measured barefoot and asked to take a full inhalation prior to stepping out from the device. Measurements are taken at the peak of the inhalation.
Measured: To be assessed at baseline and following a 12-week intervention or control period
Calf circumference (cm)
Calf circumference is measures using a non-stretch tape measure at the widest part of the calf muscle and recorded in centimetres.
Measured: To be assessed at baseline and following a 12-week intervention or control period
Perception and evaluation of the trial
Questionnaire specific to the project. This questionnaire will serve to provide feedback about participants experience while enrolled on the project. The questionnaire will include a series of Likert style questions and open-ended questions. The purpose is the provide feedback to the study team on what participants liked or disliked about the experience. This will serve to inform future management of studies.
Measured: End of trial (up to 18-weeks)
Body composition by Dual-energy X-ray absorptiometry (DXA) (sub-sample)
DXA will be performed on a sub-sample of participants enrolled on the APPETITE study. A DXA can involves a large scanning arm being passed over the body to measure compartments of the body structure. As the scanning arm is moved slowly over your body, a narrow beam of low-dose X-rays will be passed through the part of your body being examined. DXA is a quick and non-invasive scan that provides in-depth analysis of the main components of your body; fat, muscle and bone.
Measured: To be assessed at baseline and following a 12-week intervention or control period
Motor Unit Signalling (sub-sample)
by electromyography (EMG)
Measured: To be assessed at baseline and following a 12-week intervention or control period
Motor Unit Number
from muscle biopsy
Measured: To be assessed at baseline and following a 12-week intervention or control period
muscle signalling related to muscle plasticity, metabolism, denervation and muscle capillarization (sub-sample)
This refers to the analyses of muscle biopsies. Biopsies will be taken using MEDAX/BF14100-C0; Bio-Feather with coaxial 14 g 10 cm. The following parameters will then be measured in the sample using western blot with specific antibodies for total proteins or by their activated phosphorylated form: 1) markers of denervation (AChR ; agrin/MuSK/Lrp4, NCAM, Myog); 2) markers of protein turnover (atrogin1, MURF1, LC3, BNIP3, Akt-dependent mTOR and FoxO); 3) markers of mitochondrial dynamics (OPA1, DRP1) and; 4) markers of energy metabolism pathways (AMPK and PGC1alpha).
Measured: To be assessed at baseline and following a 12-week intervention or control period
Innate immune training of macrophages
Trained immunity describes the long-term functional reprogramming of innate immune cells after exposure to a primary insult which leads to an augmented response upon stimulation with the same ligand after returning to a non-activated state. Will habitual ingestion of plant protein combined with PA results in increased ability of macrophages to undertake innate immune train in adults over the age of 65. Effects will be quantified by comparing the presence of TNF alpha in human monocytes at baseline and following a 12-week intervention.
Measured: To be assessed at baseline and following a 12-week intervention or control period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Nov 2022
- Study start22 Sep 2022
- Primary completion17 Jul 2024
- Study completionSep 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Appetite LossStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Factorial
- Model description
- Randomised controlled trial, a two-by-two factorial design will define the individual and combined impact of two intervention conditions over 12 weeks
- Masking
- None (open label)
- Enrolment
- 180 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University College Dublin
- Sponsor type
- University, hospital or other
- Collaborators
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Friedrich-Alexander-Universität Erlangen-Nürnberg, University of Padova
- Responsible party
- Sponsor
- Investigators
- Helen M Roche, Professor, Principal investigator, UCDKaty Horner, PhD, Principal investigator, University College DublinMarjolein Visser, PhD, Principal investigator, VU Amsterdam
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05608707
- Sponsor's protocol ID
- LS-21-96-Roche
- Other IDs
- JPI-ERA-HDHL PREVNUT-2020-1
- Status last verified
- Dec 2024
- First submitted
- 10 Oct 2022
- Last updated
- 9 Dec 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Horner KM, Mullen B, Quinn A, Scheufele P, Gola S, Gonnelli F, Bozzato M, Pratt J, Sala W, Mullin S, Kirwan L, Dardevet D, Guillet C, De Vito G, Visser M, Volkert D, Corish CA. Plant protein, fibre and physical activity solutions to address poor appetite and prevent undernutrition in older adults: study protocol for the APPETITE randomised controlled trial. Br J Nutr. 2024 Sep 28;132(6):823-834. doi: 10.1017/S0007114524002125. Epub 2024 Oct 10.
PubMed 39387205
Study at a glance
From the registry record, last updated by the sponsor on 9 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Innovative PlAnt Protein Fibre and Physical Activity Solutions to Address Poor AppEtite and PrevenT UndernutrITion in OldEr Adults (APPETITE)
- ClinicalTrials.gov ID
- NCT05608707
- Acronym / sponsor ID
- LS-21-96-Roche
- Conditions
- Appetite Loss, Physical Inactivity, Undernutrition, Anorexia of Aging, Aging, Ageing Well
- Keywords
- appetite, energy intake, nutrition, older adults, Physical activty
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 180 participants (estimated)
- Lead sponsor
- University College DublinUniversity, hospital or other
- Collaborators
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Friedrich-Alexander-Universität Erlangen-Nürnberg, University of Padova
- Study start
- 22 Sep 2022 (actual)
- Primary completion
- 17 Jul 2024 (actual)
- Study completion
- Sep 2025 (estimated)
- First posted
- 8 Nov 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The APPETITE Trial aims to investigate the efficacy of innovative plant protein fibre (PPF) products (developed in a previous workpackage) as part of a personalised diet with/out physical activity on appetite and incidence of undernutrition in older persons from three European countries at high risk of undernutrition.
Detailed description
It is normal that dietary intake decreases as we age due to reduced activity and muscle mass. However, appetite is a key determinant of dietary intake, and poor appetite can result in undernutrition. In many instances, older adults do not recognise their appetite has decreased significantly as the decline is slow and progressive. Protein and fibre are often poorly consumed in the diets of older adults with decreased appetite, but essential for health and well-being. Interventions designed to increase appetite, or increase dietary intake despite a reduced appetite, should therefore be key to preventing undernutrition (i.e. protein-energy malnutrition as well as nutrient deficiencies). However, treatment strategies for poor appetite are not well-established.
In this multi-centre randomised controlled trial conducted in Ireland, Germany, and Italy, a two-by-two factorial design will define the individual and combined impact of two intervention conditions over 12 weeks: 1) personalised diet with focus on plant-based protein plus fibre; and 2) physical activity.
At each centre, 60 older adults (180 in total) will be randomly allocated to one of the following four groups over a 12 week period: 1) personalised diet plus physical activity program (PD + PA), 2) usual diet plus physical activity (PA), 3) personalised diet and no PA (PD), and 4) control (usual diet, no PA).
Using identical procedures, two testing visits will be completed before and after the 12 intervention or control period.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
- Number of arms
- 4
- Model description
- Randomised controlled trial, a two-by-two factorial design will define the individual and combined impact of two intervention conditions over 12 weeks
| Arm | Type | Receives |
|---|---|---|
| Personalised diet plus physical activity intervention | Experimental | Behavioral: Physical activity intervention, Dietary Supplement: Personalised nutrition interventionA personalised diet intervention involving the incorporation of the developed plant-based protein and fibre product. Participants will also undertake 2 weekly group exercise sessions incorporating strength and balance exercises, along with home-based exercise |
| Usual diet plus physical activity | Experimental | Behavioral: Physical activity interventionParticipants will consume their usual diet and undertake 2 weekly group exercise sessions incorporating strength and balance exercises, along with home-based exercise |
| Personalised diet plus usual physical activity | Experimental | Dietary Supplement: Personalised nutrition interventionA personalised diet intervention involving the incorporation of the developed plant-based protein and fibre product. |
| Control (usual diet and physical activity) | No intervention | –This arm will not be given any nutritional or physical activity support. They will be instructed to carry on with their usual activities. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (5 listed)
- Community-dwelling,
- Age 65+ years,
- BMI 19.5-30.4kg/m2,
- Inactive (<150 minutes of moderate to vigorous physical activity per week and no regular resistance training),
- Have proof of Covid-19 vaccination
Key exclusion criteria (13 listed)
- Major cognitive impairment (MMSE ≤24),
- Uncontrolled Clinical depression (CES-D >16),
- Medical condition or current medication known to impact appetite or energy intake,
- Other medical condition that may impact ability to participate in study or study outcomes,
- Heavy smoker (>10/day),
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Physical activity interventionAlso: Structured exercise programThe 12 week intervention will involve 2 weekly group exercise sessions incorporating strength and balance exercises, along with home-based exercise focused on increasing time spent walking. | Behavioural | Personalised diet plus physical activity intervention, Usual diet plus physical activity |
| Personalised nutrition interventionAlso: Plant-based protein and fibre interventionTwo Plant-based Protein and Fibre (PPF) product products have been selected from six initially developed, with best amino acid blend, taste, and bioavailability. Participants will be provided with the PPFs to consume daily as part of a personalised diet over 12 weeks. | Dietary supplement | Personalised diet plus physical activity intervention, Personalised diet plus usual physical activity |
Primary outcome
Ad libitum energy intake (kcal)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
12-week change in energy intake assessed at an an ad libitum lunch test meal
Changes in subjective appetite sensations
Time frame: To be assessed at baseline and following a 12-week intervention or control period
12-week change in appetite to be assessed by Visual Analogue Scale (VAS) during a test meal challenge. The VAS is a validated tool for assessing subjective sensations such as hunger, fullness and desire to eat. On each 100-mm line, an appetite (hunger, fullness, desire to eat) sensation was paired with the opposing sensation (for example, 'hungry' and 'not hungry').
25 secondary outcomes
7-day physical activity score as assessed by ActivPAL v4.0
Time frame: To be assessed at baseline, prior to commencing the intervention, and during week 12 of the intervention or control period
Resting Energy Expenditure (REE) (sub-sample)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Handgrip strength
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Isometric knee extension strength
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Cardiorespiratory fitness
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Physical performance
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Participants subjective rating of perceived Quality of Life as assessed by the EQ-5D-5L
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Body composition (fat mass, fat free mass) by air displacement phlethysmography (sub-sample)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Cognitive Dietary Restraint
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Dietary Record (energy, protein and fibre intake)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Appetite hormones (Ghrelin, GLP-1, & PYY) (sub-sample)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Gut metabolomic profiles and gut microbiome diversity
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Blood hormone and metabolite profile
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Body composition by Bioelectrical Impedance Analysis (BIA)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Appetite by Simplified Nutritional Appetite Questionnaire (SNAQ)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Test meal palatability by Visual Analogue Scale (VAS)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Body weight (kg)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Standing height (cm)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Calf circumference (cm)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Perception and evaluation of the trial
Time frame: End of trial (up to 18-weeks)
Body composition by Dual-energy X-ray absorptiometry (DXA) (sub-sample)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Motor Unit Signalling (sub-sample)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Motor Unit Number
Time frame: To be assessed at baseline and following a 12-week intervention or control period
muscle signalling related to muscle plasticity, metabolism, denervation and muscle capillarization (sub-sample)
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Innate immune training of macrophages
Time frame: To be assessed at baseline and following a 12-week intervention or control period
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Dec 2024.
- Background: PubMed 39387205Horner KM, Mullen B, Quinn A, Scheufele P, Gola S, Gonnelli F, Bozzato M, Pratt J, Sala W, Mullin S, Kirwan L, Dardevet D, Guillet C, De Vito G, Visser M, Volkert D, Corish CA. Plant protein, fibre and physical activity solutions to address poor appetite and prevent undernutrition in older adults: study protocol for the APPETITE randomised controlled trial. Br J Nutr. 2024 Sep 28;132(6):823-834. doi: 10.1017/S0007114524002125. Epub 2024 Oct 10.
- Study specific websiteLink provided by the sponsor.
- Study protocol paperLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Appetite Loss
Not yet recruiting
The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.
COPD (Chronic Obstructive Pulmonary Disease), Sarcopenia in Elderly
Not yet recruiting
Be Body Brave: Digital Written Exposure Therapy for Eating Disorders
Eating Disorders
RecruitingObservational study
Speech Groups for Children Living With a Sibling Who Suffers From Anorexia Nervosa
Anorexia Nervosa
Active, not recruitingPhase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
Electric Stimulation Therapy, Obesity
Enrolling by invitation
Sleep and Activity For Eating Disorders
Eating Disorders, Anorexia Nervosa
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Helen M Roche, Professor principal investigator
UCD
Katy Horner, PhD principal investigator
University College Dublin
Marjolein Visser, PhD principal investigator
VU Amsterdam
3 sites in 3 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Physical activity intervention and Personalised nutrition intervention in people with Appetite Loss and Physical Inactivity, run by University College Dublin at 3 sites in 3 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 9 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Germany, Ireland, Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Ad libitum energy intake (kcal) (time frame: To be assessed at baseline and following a 12-week intervention or control period). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05608707, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2024.